Loss of mitochondrial transmembrane potential and caspase-9 activation during apoptosis induced by the novel styryl-lactone goniothalamin in HL-60 leukemia cells

Toxicol In Vitro. 2003 Aug;17(4):433-9. doi: 10.1016/s0887-2333(03)00051-1.

Abstract

Styryl-lactones such as goniothalamin represent a new class of compounds with potential anti-cancer properties. In this study, we investigated the mechanisms of goniothalamin (GTN), a plant styryl-lactone induced apoptosis in human promyelocytic leukemia HL-60 cells. This plant extract resulted in apoptosis in HL-60 cells as assessed by the externalisation of phosphatidylserine. Using the mitochondrial membrane dye (DIOC(6)) in conjunction with flow cytometry, we found that GTN treated HL-60 cells demonstrated a loss of mitochondrial transmembrane potential (Deltapsi(m)). Further immunoblotting on these cells showed activation of initiator caspase-9 and the executioner caspases-3 and -7. Pretreatment with the pharmacological caspase inhibitor, benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone (Z-VAD.FMK) abrogated apoptosis as assessed by all of the apoptotic features in this study. In summary, our results demonstrate that goniothalamin-induced apoptosis occurs via the mitochondrial pathway in a caspase dependent manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / physiology*
  • Caspase 3
  • Caspase 7
  • Caspase 9
  • Caspases / metabolism*
  • Enzyme Activation / drug effects
  • Flow Cytometry
  • HL-60 Cells
  • Humans
  • Indicators and Reagents
  • Membrane Potentials / drug effects
  • Mitochondria / physiology*
  • Pyrones / pharmacology*

Substances

  • Indicators and Reagents
  • Pyrones
  • goniothalamin
  • CASP3 protein, human
  • CASP7 protein, human
  • CASP9 protein, human
  • Caspase 3
  • Caspase 7
  • Caspase 9
  • Caspases